Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-003838
Filing Date
2024-05-16
Accepted
2024-05-16 18:43:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3239
  Complete submission text file 0001950047-24-003838.txt   4830
Mailing Address DAY ONE BIOPHARMACEUTICALS, INC. 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address
Dubow Adam (Reporting) CIK: 0001744507 (see all company filings)

Type: 144

Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Subject) CIK: 0001845337 (see all company filings)

EIN.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40431 | Film No.: 24957240
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)